Wall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Placing a Bet

Shares of Arcturus Therapeutics (ARCT) have gained 7.5% over the past four weeks to close the last trading session at $12.81, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$60.38 indicates a potential upside of 371.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $33.97. While the lowest estimate of$32 indicates a 149.8% increase from ...